Interleukin-23, a member of the IL-6 superfamily, is stated to be epigenetically regulated in non-small-cell lung cancer (NSCLC) via both histone acetylation and DNA methylation [119]. This evidence concerns the gene IL6 and non-small cell lung carcinoma.